March 10, 2010 (UPDATED March 17, 2010) — The US Food and Drug Administration (FDA) has approved a new indication for onabotulinumtoxin A injection (Botox; Allergan, Inc) for upper limb spasticity.
Spasticity is a disabling complication of stroke, and it is uncertain whether intramuscular injections of botulinum toxin type A reduce disability in persons with spasticity of the wrist and fingers ...
The US Food and Drug Administration (FDA) has approved an expanded indication for onabotulinum toxin A (Botox, Actavis) for the treatment of adults with upper limb spasticity, according to a company ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results